PUBLICACIÓN
Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs
Macias Y. et al.
2021 Frontiers in Pharmacology
Pharmacology (Q1), Pharmacology (medical) (Q1)
JCR: 5.988
SJR: 1.143
CITAS
3
DOI
10.3389/fphar.2021.648262
EID
2-s2.0-85116528381
EISSN
1663-9812
BIBTEX
@article{PMID:34621165, title = {Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs.}, author = {Macías Y and García-Menaya JM and Martí M and Cordobés C and Jurado-Escobar R and Cornejo-García JA and Torres MJ and Blanca-López N and Canto G and Blanca M and Laguna JJ and Agúndez JAG}, doi = {10.3389/fphar.2021.648262}, journal = {Frontiers in pharmacology}, year = {2021} }
AUTORES DE LA UEX